The American Diabetes Assn. receives five-year, US$12.5M CDC grant to expand programming in multiple states to prevent type 2 diabetes; over 37 million Americans have diabetes, 96 million have prediabetes

Sample article from our Government & Public Policy

ARLINGTON, Virginia , June 23, 2023 (press release) –

Press release

The ADA’s largest CDC grant will target the diabetes belt to prevent type 2 diabetes

Today, the American Diabetes Association® (ADA) announced that it has received a $12.5 million grant from the Centers for Disease Control and Prevention (CDC) to build upon the CDC’s National Diabetes Prevention Program (National DPP). The National DPP directly aligns with the ADA’s mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes.

The five-year grant will allow the ADA to reach thousands of people across multiple states within the diabetes belt aiming to decrease type 2 diabetes risk among adults with prediabetes while identifying and addressing social determinants of health (SDOH). The priority populations for the ADA’s programming will be African/Black Americans, Hispanic/Latino Americans, and older Americans—all of whom experience disproportionately higher risk and burdens of diabetes.

"As the world's standard setter for diabetes prevention and care, we take our responsibility to bend the curve on diabetes seriously. Doing so requires innovative new approaches in diabetes prevention," said Charles "Chuck" Henderson, chief executive officer of the ADA. "This grant is the largest the CDC has ever provided the ADA and marks an important and exciting time for our organization. It gives us a chance to do what we do best on an even greater scale: Combining our clinical leadership with our commitment to caring for people in the communities where they live."

Recognizing that bending the curve on type 2 diabetes is a team approach, the ADA will partner with community health workers, pharmacists, payers, and community-based organizations to increase National DPP enrollment and engage with multiple payer partners to scale the program. The ADA and its partners will collaborate to increase National DPP enrollment, address SDOH, and apply innovative payment models to improve National DPP coverage.

"Over 37 million Americans have diabetes, and an astonishing 96 million have prediabetes—many of whom are unaware of it. It is urgent that all of us do more to address this situation. This tremendous partnership with the CDC enables us to fully leverage the ADA’s existing diabetes prevention work, focusing on communities where the risk of diabetes and prediabetes are most prevalent," said Dr. Robert Gabbay, chief scientific and medical officer of the ADA and principal investigator for the grant. "We are particularly excited to take on this critical work in ways that fully engage other key stakeholders, including payers, community health workers, tech innovators, and most importantly, the patient community."

Visit to learn more about ADA’s implementation of National DPP.


* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Chelsey Quick
Chelsey Quick
- VP Client Success -

We offer built-to-order government & public policy coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.